Inclusion of Human Chorionic Gonadotropin in the Family of Therapeutic Glycoproteins

Journal Title: Women's Health – Open Journal - Year 2017, Vol 3, Issue 1

Abstract

The family of therapeutic glycoproteins contains many members. Some of them have become valuable therapeutic agents in saving the countless number of human lives from some of the most dreadful diseases. They are increasingly taking a center stage among biotherapeutics. The technologies of glycoengineering are making a further impact by modifying the glycan moieties, which make them biologically more active and increase their effectiveness and pharmacokinetics, etc. Human Chorionic Gonadotropin (hCG) has been used in reproductive medicine for the last several decades. The paradigm shift on the hCG actions has created additional therapeutic opportunities against many menacing and dangerous diseases that are no less important than the ones treated by some of the prominent members of the therapeutic glycoproteins family. However, to the best of the authors’ knowledge, hCG has never been included in this family or tapped the potential of glycoengineering to make hCG even more therapeutically effective than the currently used preparations. It is time to include hCG in the family and begin glycoengineering on recombinant hormone.

Authors and Affiliations

C. V. Rao

Keywords

Related Articles

Shared Decision-Making Regarding Place of Birth–Mission Impossible or Mission Accomplished?

Aim: To explore Dutch pregnant women’s experiences of shared-decision making about place of birth to better understand this process for midwifery care purposes. Design: Qualitative exploratory study with a constant compa...

Women and Heart Disease: Understanding Risk Factors for Coronary Artery Disease

Cardiovascular disease (CVD) is the leading cause of death in women in the US. Although the overall death rate due to CVD has decreased recently, it has actually increased in young women. Coronary Artery Disease (CAD), w...

Towards Increasing Contraceptive Prevalence in Burkina Faso through Task Sharing

The prevalence of contraception in Burkina Faso (BF) has increased in the past 18 years from 5.8%1 in 1998 to 25%2 in 2016; an increase of 1% per year while population growth remains strong and stable at 3.1% per year. T...

The Current State of Professional Midwives in Japan and their Traditional Virtues

Traditionally, Japanese women endure labor pain. They are then pleased by the sense of accomplishment after a successful vaginal childbirth, a concept based on the Japanese Buddhism. Therefore, Japanese midwives place im...

Risk Factors and Barriers to Male Involvement in the Choice of Family Planning Methods in the Buea Health District, South West Region,Cameroon: A Cross-Sectional Study in a Semi-Urban Area

Background: Family Planning (FP) promotion and services are often focused on women, but nonetheless men have an important role to play also. Engaging men in family planning programs and services has the potential to impr...

Download PDF file
  • EP ID EP554903
  • DOI 10.17140/WHOJ-3-119
  • Views 140
  • Downloads 0

How To Cite

C. V. Rao (2017). Inclusion of Human Chorionic Gonadotropin in the Family of Therapeutic Glycoproteins. Women's Health – Open Journal, 3(1), 30-35. https://europub.co.uk/articles/-A-554903